Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
- 9 January 2009
- Vol. 27 (9) , 1454-1467
- https://doi.org/10.1016/j.vaccine.2008.12.024
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Cost-Effectiveness of a Vaccine To Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsAnnals of Internal Medicine, 2006
- The burden of Herpes Zoster: A prospective population based studyVaccine, 2006
- The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trialThe Lancet, 2006
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- A study of shingles and the development of postherpetic neuralgia in East LondonJournal of Medical Virology, 2003
- Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research databaseFamily Practice, 2002
- Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow upBMJ, 2000
- Modelling the impact of immunization on the epidemiology of varicella zoster virusEpidemiology and Infection, 2000
- The lifetime occurrence of Herpes zoster and prevalence of post‐herpetic neuralgia: A retrospective survey in an elderly populationEuropean journal of pain, 1999
- Pain and its persistence in herpes zosterPain, 1996